Tonix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.76-$72 |
Market Cap | $195M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $9.8M |
Revenue Growth (YoY) | -9.5% |
Gross Profit (12 Mos) | $2.8M |
Diluted EPS | $2,537 |
News
See moreYahoo Finance • 11 days ago
Tonix Pharmaceuticals Holding Corp (TNXP) Showcases Promising TNX-801 Vaccine Data
Yahoo Finance • 13 days ago
Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence
Yahoo Finance • 18 days ago
Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital
Yahoo Finance • 23 days ago
Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025
About
CEO | Dr. Seth Lederman M.D. |
CFO | Mr. Bradley Saenger CPA |
Address | 26 Main Street, Chatham, NJ, United States, 07928 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
